Distinct genomic signatures and modifiable risk factors underly the comorbidity between major depressive disorder and
Jacob Bergstedt1, Joëlle A Pasman2, Ziyan Ma2
1Unit of Integrative Epidemiology, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.
Insights
Major depressive disorder (MDD) and cardiovascular disease (CVD) share genetic factors, with MDD liability causally impacting CVD risk. Understanding these links can help prevent CVD in MDD patients.
Area of Science:
- Genetics
- Psychiatry
- Cardiology
Background:
- Major depressive disorder (MDD) and cardiovascular disease (CVD) frequently co-occur, increasing health risks.
- Genomic insights are crucial for understanding the biological basis of this comorbidity.
Approach:
- Utilized multivariate genome-wide association analysis on shared genetic liability between MDD and atherosclerotic CVD (ASCVD).
- Investigated shared inflammatory, metabolic, and psychosocial/lifestyle risk factors.
- Performed causal inference analyses to determine the directionality of effects.
Key Points:
- Identified seven novel genetic loci associated with shared MDD-ASCVD liability, with enrichment in the thalamus.
- Found that genetic overlap is partly explained by shared inflammatory, metabolic, and lifestyle factors.
- Demonstrated a causal effect of genetic liability for MDD on CVD risk, mediated by metabolic and lifestyle factors.
Conclusions:
- The comorbidity suggests an immunometabolic subtype of MDD with higher CVD association.
- Identified biological mechanisms and modifiable risk factors for preventing CVD in individuals with MDD.
Abstract:
Major depressive disorder (MDD) and cardiovascular disease (CVD) are often comorbid, resulting in excess morbidity and mortality. Using genomic data, this study elucidates biological mechanisms, key risk factors, and causal pathways underlying their comorbidity. We show that CVDs share a large proportion of their genetic risk factors with MDD. Multivariate genome-wide association analysis of the shared genetic liability between MDD and atherosclerotic CVD (ASCVD) revealed seven novel loci and distinct patterns of tissue and brain cell-type enrichments, suggesting a role for the thalamus. Part of the genetic overlap was explained by shared inflammatory, metabolic, and psychosocial/lifestyle risk factors. Finally, we found support for causal effects of genetic liability to MDD on CVD risk, but not from most CVDs to MDD, and demonstrated that the causal effects were partly explained by metabolic and psychosocial/lifestyle factors. The distinct signature of MDD-ASCVD comorbidity aligns with the idea of an immunometabolic sub-type of MDD more strongly associated with CVD than overall MDD. In summary, we identify plausible biological mechanisms underlying MDD-CVD comorbidity, as well as key modifiable risk factors for prevention of CVD in individuals with MDD.
More Related Videos
08:51Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts
Published on: September 20, 2024
08:15Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
Published on: June 6, 2025
Related Concept Videos
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
Coronary Artery Disease I: Introduction
Depressive Disorders: Etiology
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Human Genetics
The complex relationship between genetics and psychology is observable through common biological components such...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Coronary Artery Disease II: Pathophysiology
